TriSalus Life Sciences, Inc.

Q2 2026 13F Holders

Symbol: TLSI
CUSIP: 89680M101
Type: Equity
Class: COM
Num filings: 80
Total reported value, excl. options: $104 M

Compare 2026 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type